Beacon Biosignals’ Post

𝗜𝗺𝗽𝗿𝗼𝘃𝗶𝗻𝗴 𝗣𝗮𝘁𝗶𝗲𝗻𝘁 𝗘𝘅𝗽𝗲𝗿𝗶𝗲𝗻𝗰𝗲 & 𝗗𝗮𝘁𝗮 𝗤𝘂𝗮𝗹𝗶𝘁𝘆 𝘄𝗶𝘁𝗵 𝗕𝗲𝗮𝗰𝗼𝗻’𝘀 𝗗𝗿𝗲𝗲𝗺 𝟯𝗦 𝗘𝗘𝗚 𝗛𝗲𝗮𝗱𝗯𝗮𝗻𝗱 Clinical trials depend on high-quality, reliable data—but when it comes to sleep studies, traditional in-lab polysomnography (PSG) presents significant challenges. PSG is burdensome for patients, leading to poor usability scores and potential disruptions in natural sleep patterns. 📊 New data confirms that patients overwhelmingly prefer Beacon's Dreem 3S headband over PSG in clinical trials, as shown in System Usability Scale (SUS) scores (first image). The Dreem 3S provides PSG-equivalent data in an at-home, consumer-grade device designed for patient comfort. A better patient experience translates to higher compliance and more consistent data collection. 🔬 Because Dreem 3S eliminates the "first night" effect, baseline sleep data is more reliable from the start (second image). In contrast, the unfamiliar lab environment of PSG often disrupts sleep on the first night, potentially skewing results. By improving usability and reducing study complexity, Dreem 3S enables more scalable, patient-friendly, and data-rich CNS clinical trials. Contact us to learn more about the Deem 3S EEG Headband: https://lnkd.in/errYwFaE #EEG #CNSDrugDevelopment #SleepResearch #ClinicalTrials #PrecisionMedicine